Mice with active infections had EcoHIV, the mouse equivalent of human HIV-1. Using CRISPR/Cas9, researchers were able to block replication of the virus and show they could potentially prevent ...

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

Early reports have demonstrated that CRISPR effectively excises integrated human immunodeficiency virus type 1 (HIV) from cells. 1,2 For Michele Lai from the University of Pisa, these studies raised ...

Globally, people get animal protein mostly from chickens, with pigs and cattle in second and third place. A 2023 report ...

Since the discovery of precise gene editing technologies like CRISPR, researchers have been investigating the possibility of ‘erasing’ HIV DNA from cells, as a potential cure strategy.

He claims to have used Crispr to target and knock out the CCR5 gene in human embryos, which is linked to HIV infection. And then he did something that shocked the scientific community. He ...

Targeting HIV-1 with CRISPR/Cas9 stops the virus from replicating, but can also help it escape, two recent studies show. Exploring viral replication pathways has led Carol Carter from the study of ...

No writing assistance was utilized in the production of this manuscript. Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting ...